Literature DB >> 31985086

Gastric-type gene expression and phenotype in non-terminal respiratory unit type adenocarcinoma of the lung with invasive mucinous adenocarcinoma morphology.

Myoung Ju Koh1, Dong Hoon Shin1, So-Jeong Lee1, Chung-Su Hwang1, Hyun Jung Lee1, Ahrong Kim1, Won Young Park1, Jung Hee Lee1, Kyung Un Choi1, Jee Yeon Kim1, Chang Hun Lee1, Mee Young Sol1.   

Abstract

AIMS: We sought to determine if non-terminal respiratory unit (TRU) type adenocarcinoma of lung with invasive mucinous adenocarcinoma (IMA) morphology shows gastric differentiation. METHODS AND
RESULTS: We reviewed whole-section images of 489 cases of lung adenocarcinoma from The Cancer Genome Atlas (TCGA). TCGA data were classified into 426 TRU type adenocarcinoma, 49 IMA and 14 unclassifiable. Their RNA sequencing data was analysed by DESeq2 and WGCNA R packages. Gene expression in patients' samples was measured by NanoString assay. Overexpression of genes including REG4, TFF2, MUCL3, FER1L6, B3GALT5, ANXA10 was observed by TCGA analysis in IMA compared to TRU type adenocarcinoma. Many of these genes are those expressed in normal gastric glands and selected for NanoString experiment on 14 IMA and 10 TRU type adenocarcinoma cases. The expression of genes, including ANXA10, FER1L6, HNF4a, MUC5AC, REG4, TFF1, TFF2 and VSIGI, was increased> 15-fold in IMA. Immunohistochemistry of ANXA10, TFF2 and FER1L6 performed on 31 IMA and 135 TRU type adenocarcinomas showed a predominant expression in IMA, but are not in TRU type adenocarcinoma.
CONCLUSION: Our results showed the level of genes expressed in stomach mucosa was increased in IMA compared to TRU type adenocarcinoma, supporting gastric differentiation of IMA. This finding may help the understanding of the pathogenesis of IMA and discovery of therapeutic targets.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  gastric differentiation; gene expression; invasive mucinous adenocarcinoma; non-TRU type adenocarcinoma

Mesh:

Substances:

Year:  2020        PMID: 31985086     DOI: 10.1111/his.14077

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Diffuse expression of MUC6 defines a distinct clinicopathological subset of pulmonary invasive mucinous adenocarcinoma.

Authors:  Satsuki Kishikawa; Takuo Hayashi; Tsuyoshi Saito; Kazuya Takamochi; Shinji Kohsaka; Kei Sano; Noriko Sasahara; Keita Sasa; Taisei Kurihara; Kieko Hara; Yoshiyuki Suehara; Fumiyuki Takahashi; Kenji Suzuki; Takashi Yao
Journal:  Mod Pathol       Date:  2020-10-06       Impact factor: 7.842

Review 2.  The Clinical Significance and Mechanisms of REG4 in Human Cancers.

Authors:  Junyan Zhang; Zhi Zhu; Zhifeng Miao; Xuanzhang Huang; Zhe Sun; Huimian Xu; Zhenning Wang
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

3.  TFF-1 Functions to Suppress Multiple Phenotypes Associated with Lung Cancer Progression.

Authors:  Kentaro Minegishi; Yoh Dobashi; Hiroyoshi Tsubochi; Koichi Hagiwara; Yuko Ishibashi; Sachiyo Nomura; Ritsuko Nakamura; Yasukazu Ohmoto; Shunsuke Endo
Journal:  Onco Targets Ther       Date:  2021-09-10       Impact factor: 4.147

Review 4.  The role of hepatocyte nuclear factor 4α (HNF4α) in tumorigenesis.

Authors:  Lei Sang; Xingshun Wang; Weiyu Bai; Junling Shen; Yong Zeng; Jianwei Sun
Journal:  Front Oncol       Date:  2022-09-28       Impact factor: 5.738

5.  Age and Sex-Related Changes in Human First-Trimester Placenta Transcriptome and Insights into Adaptative Responses to Increased Oxygen.

Authors:  Fulin Liu; Christelle Simasotchi; Françoise Vibert; Wencan Zhu; Sophie Gil; Séverine A Degrelle; Thierry Fournier
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

6.  Secondary data mining of GEO database for long non-coding RNA and Competing endogenous RNA network in keloid-prone individuals.

Authors:  Yu Deng; Yangbin Xu; Shuqia Xu; Yujing Zhang; Bing Han; Zheng Liu; Xiangxia Liu; Zhaowei Zhu
Journal:  Aging (Albany NY)       Date:  2020-11-16       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.